1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Gene Therapy Market
2.3. Global Gene Therapy Market, By Product, 2025 (US$ Million)
2.4. Global Gene Therapy Market, By End-user, 2025 (US$ Million)
2.5. Global Gene Therapy Market, By Geography, 2025 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2025

3. Gene Therapy Market: Competitive Analysis
3.1. Market Positioning of Key Gene Therapy Market Vendors
3.2. Strategies Adopted by Gene Therapy Market Vendors

4. Gene Therapy Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Gene Therapy Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape

5. Gene Therapy Market: By Product, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Instruments
5.3.2. Media
5.3.3. Sera
5.3.4. Reagents

6. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Biotechnology Companies
6.3.2. Pharmaceutical Companies
6.3.3. Academic Institutes
6.3.4. Research Institutes

7. North America Gene Therapy Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Gene Therapy Market: By Product, 2024-2034, USD (Million)
7.3. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
7.4. Gene Therapy Market: By Region, 2024-2034, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
7.4.1.1.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
7.4.1.2.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
7.4.1.3.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)

8. UK and European Union Gene Therapy Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Gene Therapy Market: By Product, 2024-2034, USD (Million)
8.3. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
8.4. Gene Therapy Market: By Region, 2024-2034, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
8.4.1.1.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
8.4.1.2.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
8.4.1.3.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
8.4.1.4.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
8.4.1.5. France
8.4.1.5.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
8.4.1.5.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
8.4.1.6.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)

9. Asia Pacific Gene Therapy Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Gene Therapy Market: By Product, 2024-2034, USD (Million)
9.3. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
9.4. Gene Therapy Market: By Region, 2024-2034, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
9.4.1.1.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
9.4.1.2.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
9.4.1.3. India
9.4.1.3.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
9.4.1.3.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
9.4.1.4.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
9.4.1.5.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
9.4.1.6.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)

10. Latin America Gene Therapy Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Gene Therapy Market: By Product, 2024-2034, USD (Million)
10.3. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
10.4. Gene Therapy Market: By Region, 2024-2034, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
10.4.1.1.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
10.4.1.2.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
10.4.1.3.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)

11. Middle East and Africa Gene Therapy Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Gene Therapy Market: By Product, 2024-2034, USD (Million)
11.3. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
11.4. Gene Therapy Market: By Region, 2024-2034, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
11.4.1.1.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
11.4.1.2.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Gene Therapy Market: By Product, 2024-2034, USD (Million)
11.4.1.3.2. Gene Therapy Market: By End-user, 2024-2034, USD (Million)

12. Company Profile
12.1. Novartis AG (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. Orchard Therapeutics Limited
12.3. Celgene Corporation
12.4. Spark Therapeutics, Inc.
12.5. Gilead Sciences, Inc.
12.6. Sibiono GeneTech Co. Ltd.